Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-100
Closed -$45 9243
2025
Q2
$45 Sell
100
-28,700
-100% -$12.5K ﹤0.01% 7807
2025
Q1
$11.7K Sell
28,800
-53,600
-65% -$34.4K ﹤0.01% 6153
2024
Q4
$54.6K Sell
82,400
-18,600
-18% -$12.9K ﹤0.01% 4988
2024
Q3
$85.7K Buy
101,000
+38,900
+63% +$29.7K ﹤0.01% 4299
2024
Q2
$41.4K Sell
62,100
-1,900
-3% -$1.58K ﹤0.01% 4657
2024
Q1
$83.2K Buy
64,000
+50,500
+374% +$52.9K ﹤0.01% 4302
2023
Q4
$7.73K Buy
13,500
+1,400
+12% +$968 ﹤0.01% 6323
2023
Q3
$9.12K Sell
12,100
-8,800
-42% -$6.69K ﹤0.01% 6382
2023
Q2
$15.3K Buy
20,900
+1,300
+7% +$1.21K ﹤0.01% 6159
2023
Q1
$14.8K Sell
19,600
-100,500
-84% -$93.3K ﹤0.01% 5712
2022
Q4
$115K Sell
120,100
-64,800
-35% -$91.6K ﹤0.01% 4313
2022
Q3
$403K Buy
184,900
+16,900
+10% +$58.3K ﹤0.01% 3448
2022
Q2
$588K Sell
168,000
-200
-0.1% -$747 ﹤0.01% 3273
2022
Q1
$848K Sell
168,200
-187,700
-53% -$951K ﹤0.01% 3259
2021
Q4
$2.23M Sell
355,900
-108,200
-23% -$739K ﹤0.01% 2483
2021
Q3
$3.69M Buy
464,100
+114,400
+33% +$942K ﹤0.01% 2018
2021
Q2
$2.62M Sell
349,700
-233,400
-40% -$1.63M ﹤0.01% 2360
2021
Q1
$3.53M Sell
583,100
-87,800
-13% -$675K 0.01% 1869
2020
Q4
$3.83M Buy
670,900
+418,900
+166% +$2.66M 0.01% 1491
2020
Q3
$1.68M Buy
+252,000
New +$2.24M 0.01% 1758

Other funds holding VXRT

Group One Trading's VXRT Position: Q3 2025 in Review

Group One Trading sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 41,043 shares — an estimated $18.6K sold.

Group One Trading first reported a position in VXRT in Q2 2013 and held it in 36 quarters. The position peaked at $951K in Q2 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Group One Trading reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 41,043 Vaxart shares in Q3 2025, an estimated $18.6K.
  • Group One Trading first reported a position in Vaxart in Q2 2013 and held it in 36 quarters.
  • Group One Trading's Vaxart position peaked at $951K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.